Biosimilar Consulting Services

If you're looking for an experienced partner in biosimilar development, you've come to the right place.

One of the most exciting facets of biosimilar development is the opportunity to take advantage of an abbreviated pathway to FDA licensure. However, the increasing number of biosimilar products that are slated to enter the drug pipeline in the next few years will face a unique set of regulatory requirements.

Having played a significant role in most approved biosimilars in the U.S. market, Cardinal Health Regulatory Sciences has the biosimilar consulting experience you need to navigate complex regulatory requirements.

A proven track record in an exciting, growing market

Biosimilars may benefit from a shorter road to approval – but you still need a partner with proven experience to help you navigate the process as quickly and compliantly as possible.

Our biosimilar consulting experts have the experience you need to successfully navigate complex clinical development and regulatory processes so you can get your biosimilar products in the hands of patients, faster.

Contact our experts today

Put our proven biosimilar consulting expertise to work for you. Contact us today to learn how we can get your therapy in the hands of patients, faster.

*
*
*
*
 A CDA
 More information
 A cost proposal
 
 

>33%